Kevin M McCoy

Title: Kevin M McCoy: Innovator in Pharmaceutical Processes

Introduction

Kevin M McCoy is a notable inventor based in Hudson, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes that enhance the synthesis of important compounds. With a total of 3 patents to his name, McCoy's work has implications for the treatment of various health conditions.

Latest Patents

One of McCoy's latest patents is focused on a process improvement for producing [R-(R*, R*)]-5-(3-chlorophenyl)-3-[2-(3,4-dihydroxyphenyl)-1-methylethyl]-2-oxazolidinone. This compound serves as an intermediate in the creation of medications that possess antidiabetic, antihyperglycemic, and antiobesity properties in mammals. Another significant patent involves a method for the solubilization and naturation of somatotropins. This process utilizes a combination of sulfolane and an aqueous alkaline solution, resulting in enhanced yields of the end product.

Career Highlights

Kevin M McCoy is currently associated with American Cyanamid Company, where he applies his expertise in pharmaceutical innovations. His work has been instrumental in advancing methods that improve the efficiency and effectiveness of drug synthesis.

Collaborations

Throughout his career, McCoy has collaborated with esteemed colleagues such as Robert A Frost and William T Cain. These partnerships have contributed to the successful development of his patented processes.

Conclusion

Kevin M McCoy stands out as an influential inventor in the pharmaceutical industry. His innovative approaches to process improvement have the potential to significantly impact the treatment of various health conditions.